ArticleFrontiers in pediatrics2025
A support vector machine-based tool for rapid pediatric asthma exacerbation risk assessment: development and nursing application.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Childhood asthma poses a significant threat to pediatric health, and traditional assessment methods are often inadequate in efficiency and accuracy. This study aims to develop a rapid assessment tool for pediatric asthma exacerbation risk based on the support vector machine (SVM) algorithm and evaluate its value in nursing practice. Methods: Clinical data from children with asthma were collected, incorporating key indicators including eczema, allergic rhinitis (AR), family medical history (FMH), dyspnea, white blood cell count (WBC), immunoglobulin E (IgE), and fractional exhaled nitric oxide (FeNO). An SVM-based risk prediction model was developed. Utilizing Plumber, an application programming interface (API) was constructed to enable data transmission and real-time risk assessment. The pediatric asthma risk rapid tool (PARRT) mini-program was subsequently developed. Service quality metrics were compared before and after PARRT implementation. Results: The constructed SVM model demonstrated excellent performance on the test dataset, achieving an area under the curve (AUC) of 0.9998. Clinical application revealed that PARRT significantly reduced patient wait time, decreased report wait time, improved satisfaction scores among patients and their families, as well as enhanced nursing staff efficiency. Conclusion: PARRT exhibits strong predictive accuracy and holds considerable promise for clinical utility in pediatric asthma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.